Literature DB >> 27130059

Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.

Erkin Aribal1, Ruslan Asadov2, Abdullah Ramazan3, Mustafa Ümit Ugurlu4, Handan Kaya5.   

Abstract

OBJECTIVES: To evaluate the diagnostic accuracy of dynamic contrast enhanced breast MRI (DCE-MRI) combined with diffusion weighted imaging (DWI) and 1H single-voxel magnetic resonance spectroscopy (1HMRS) in differentiating malignant from benign breast lesions.
METHODS: One hundred twenty-nine patients with 138 lesions were included in the study. Multiparametric MRI of the breast was performed with a 3T unit. A DWI is followed by DCE-MRI and 1HMRS. All lesions were biopsied within one week after MRI. Histopathologic findings were accepted as the standard of reference. Probability of malignancy was assessed according to BI-RADS for DCE-MRI. ADC values were measured for DWI and choline peaks were assessed using a semi-quantitative method in 1HMRS. Two blinded radiologists evaluated findings in consensus. Diagnostic performance of DCE-MRI, DWI and 1HMRS alone or in combination for multiparametric imaging were statistically evaluated.
RESULTS: Histopathology revealed malignancy in 54.4% of lesions (75/138). DCE-MRI showed the highest AUC (0.978), sensitivity (97.33%) and specificity (88.89%) compared to DWI and 1HMRS. Sensitivity was 100% when a positive result from any one of three techniques was accepted as malignancy, albeit with a trade-off for 65.1% specificity. Highest specificity (98.4%) was attained when all three techniques were required to be positive, though with a lower sensitivity (82.7%) as trade-off. Logistic regression analysis confirmed significant association with DCE-MRI (p<0.001) and 1H MRS (p=0.009) but not with DWI (p=0.127). There was one case of fat necrosis which was false positive in all three techniques.
CONCLUSIONS: Multiparametric imaging with combination of DCE-MRI, DWI and 1HMRS does not improve, and may even reduce the diagnostic accuracy of breast MRI. Although, the specificity may be improved with a trade-off for lower sensitivity, we have not set a convenient algorithm for the combined use of these techniques.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  1H single voxel MR spectroscopy; Breast cancer; Diffusion weighted imaging; Dynamic contrast enhanced magnetic resonance imaging; Fat necrosis; Mucinous cancer; Multiparametric MRI

Mesh:

Substances:

Year:  2016        PMID: 27130059     DOI: 10.1016/j.ejrad.2016.02.022

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  9 in total

Review 1.  Clinical role of breast MRI now and going forward.

Authors:  D Leithner; G J Wengert; T H Helbich; S Thakur; R E Ochoa-Albiztegui; E A Morris; K Pinker
Journal:  Clin Radiol       Date:  2017-12-09       Impact factor: 2.350

2.  Magnetic resonance biomarkers in radiation oncology: The report of AAPM Task Group 294.

Authors:  Kiaran P McGee; Ken-Pin Hwang; Daniel C Sullivan; John Kurhanewicz; Yanle Hu; Jihong Wang; Wen Li; Josef Debbins; Eric Paulson; Jeffrey R Olsen; Chia-Ho Hua; Lizette Warner; Daniel Ma; Eduardo Moros; Neelam Tyagi; Caroline Chung
Journal:  Med Phys       Date:  2021-05-20       Impact factor: 4.071

Review 3.  Diffusion magnetic resonance imaging: A molecular imaging tool caught between hope, hype and the real world of "personalized oncology".

Authors:  Abhishek Mahajan; Sneha S Deshpande; Meenakshi H Thakur
Journal:  World J Radiol       Date:  2017-06-28

4.  Can apparent diffusion coefficient (ADC) distinguish breast cancer from benign breast findings? A meta-analysis based on 13 847 lesions.

Authors:  Alexey Surov; Hans Jonas Meyer; Andreas Wienke
Journal:  BMC Cancer       Date:  2019-10-15       Impact factor: 4.430

Review 5.  Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism.

Authors:  Uma Sharma; Naranamangalam R Jagannathan
Journal:  Metabolites       Date:  2022-03-27

Review 6.  Diagnostic Performance of Diffusion Kurtosis Imaging for Benign and Malignant Breast Lesions: A Systematic Review and Meta-Analysis.

Authors:  Hongyu Gu; Wenjing Cui; Song Luo; Xiaoyi Deng
Journal:  Appl Bionics Biomech       Date:  2022-06-09       Impact factor: 1.664

Review 7.  Imaging biomarkers for evaluating tumor response: RECIST and beyond.

Authors:  Ching-Chung Ko; Lee-Ren Yeh; Yu-Ting Kuo; Jeon-Hor Chen
Journal:  Biomark Res       Date:  2021-07-02

8.  Apparent Diffusion Coefficient to Subdivide Breast Imaging Reporting and Data System Magnetic Resonance Imaging (BI-RADS-MRI) Category 4 Lesions.

Authors:  Dandan Liu; Zhaogui Ba; Xiaoli Ni; Linhong Wang; Dexin Yu; Xiangxing Ma
Journal:  Med Sci Monit       Date:  2018-04-12

Review 9.  In vivo MR spectroscopy for breast cancer diagnosis.

Authors:  Uma Sharma; Naranamangalam Raghunathan Jagannathan
Journal:  BJR Open       Date:  2019-07-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.